Growth Metrics

HNO International (HNOI) Common Equity (2022 - 2026)

HNO International filings provide 5 years of Common Equity readings, the most recent being -$1.7 million for Q1 2026.

  • On a quarterly basis, Common Equity rose 3.09% to -$1.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$1.7 million, a 3.09% increase, with the full-year FY2025 number at -$1.6 million, down 16.64% from a year prior.
  • Common Equity hit -$1.7 million in Q1 2026 for HNO International, down from -$1.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $296105.0 in Q3 2023 to a low of -$1.8 million in Q1 2025.
  • Median Common Equity over the past 5 years was -$1.1 million (2022), compared with a mean of -$1.1 million.
  • Biggest five-year swings in Common Equity: surged 135.59% in 2023 and later tumbled 623.72% in 2024.
  • HNO International's Common Equity stood at -$1.1 million in 2022, then soared by 82.61% to -$193085.0 in 2023, then tumbled by 623.72% to -$1.4 million in 2024, then fell by 16.64% to -$1.6 million in 2025, then dropped by 4.12% to -$1.7 million in 2026.
  • The last three reported values for Common Equity were -$1.7 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025) per Business Quant data.